EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case‐Control Study on the Association Between MMP2 and MMP9 Genetic Polymorphisms and Breast Cancer

Pulak Chowdhury, Md Abdul Aziz iD, Tahmina Akter, Mohammad Safiqul Islam iD, Md Shahid Sarwar

Health Science Reports · 2025-08 · 8 (8)

DOI: 10.1002/hsr2.71123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 28.07.2025. Verfasst von Pulak Chowdhury und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Noakhali Science and Technology University Noakhali Bangladesh. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Matrix metalloproteinase 2 (MMP2) and MMP9 are associated with the degradation of type IV collagen, leading to invasion and metastasis. Polymorphisms in these genes could influence their biological activities and contribute to cancer development and progression. This study evaluated the relationship between MMP2 (rs2285053) and MMP9 (rs3787268) gene polymorphisms and the susceptibility to breast cancer in Bangladeshi breast cancer patients.

Methods

This case‐control study included 105 females diagnosed with breast cancer and 108 healthy controls. Following DNA extraction from the blood samples, genotyping was carried out by tetra‐primer amplification refractory mutation system‐polymerase chain (ARMS‐PCR) reaction and gel electrophoresis.

Results

In the case of rs2285053 polymorphism, CT genotype (OR = 2.12, 95% CI = 1.03–4.36), dominant model (OR = 2.21, 95% CI = 1.08–4.52), overdominant model (OR = 2.10, 95% CI = 1.02–4.31), and alleles (OR = 2.13, CI = 1.08–4.18) were significantly associated with an increased breast cancer risk. For rs3787268 polymorphism, additive model 1 (OR = 0.20, 95% CI = 0.05–0.78), additive model 2 (OR = 0.23, 95% CI = 0.06–0.86), and dominant model (OR = 0.22, CI = 0.06–0.81) significantly decreased breast cancer risk in this population.

Conclusion

Our results conclude that MMP2 (rs2285053) is associated with an increased risk of breast cancer, while MMP9 (rs3787268) polymorphisms may be correlated with a reduced risk of breast cancer in Bangladeshi females. Future studies are warranted to validate our findings in other populations.

Schlagwörter

Stichwörter der Autor:innen

MMP2MMP9breast cancerpolymorphismrs2285053rs3787268

Autor:innen und Institutionen

  • Department of Pharmacy Noakhali Science and Technology University Noakhali Bangladesh.

ORCID-Profile: Md Abdul Aziz, Mohammad Safiqul Islam

Zitieren

APA

Chowdhury, P., Aziz, M. A., Akter, T., Islam, M. S., & Sarwar, M. S. (2025). A Case‐Control Study on the Association Between MMP2 and MMP9 Genetic Polymorphisms and Breast Cancer. Health Science Reports, 8(8). https://doi.org/10.1002/hsr2.71123

Vancouver

Chowdhury P, Aziz MA, Akter T, Islam MS, Sarwar MS. A Case‐Control Study on the Association Between MMP2 and MMP9 Genetic Polymorphisms and Breast Cancer. Health Science Reports. 2025;8(8). doi:10.1002/hsr2.71123

BibTeX
@article{Chowdhury2025,
  author = {Chowdhury, Pulak and Aziz, Md Abdul and Akter, Tahmina and Islam, Mohammad Safiqul and Sarwar, Md Shahid},
  title = {A Case‐Control Study on the Association Between MMP2 and MMP9 Genetic Polymorphisms and Breast Cancer},
  journal = {Health Science Reports},
  year = {2025},
  volume = {8},
  number = {8},
  doi = {10.1002/hsr2.71123}
}
Kostenlos starten →